{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:14Z","timestamp":1791582674136,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05620-2","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:18:59Z","timestamp":1782911939000},"page":"19933-19948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isatin-based oxime ethers as anticancer agents against human colorectal carcinoma"],"prefix":"10.1007","volume":"399","author":[{"given":"Shashikala Mariswamy","family":"Rajesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshini A.","family":"N.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Kumar D.","family":"C.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhanva Muddenahalli","family":"Srinivasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toreshettahally R.","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaghatta N.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobith","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchugarakoppal S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"5620_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/ml400045j","volume":"4","author":"D Barnes-Seeman","year":"2013","unstructured":"Barnes-Seeman D, Jain M, Bell L, Ferreira S, Cohen S, Chen X-H, Amin J, Snodgrass B, Hatsis P (2013) Metabolically stable tert-butyl replacement. ACS Med Chem Lett 4:514\u2013516","journal-title":"ACS Med Chem Lett"},{"key":"5620_CR2","unstructured":"Biovia DS (2017) Discovery studio modeling environment, Release"},{"key":"5620_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08830185.2012.664797","volume":"31","author":"JJ Buggy","year":"2012","unstructured":"Buggy JJ, Elias L (2012) Bruton tyrosine kinase (BTK) and its role in B-cell malignancy. Int Rev Immunol 31:119\u2013132","journal-title":"Int Rev Immunol"},{"key":"5620_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2025.102944","volume":"48","author":"MI Chamanmalik","year":"2025","unstructured":"Chamanmalik MI, Kempegowda BB, Sudhanva MS, Somappa SB, Patil SA (2025) Biomedically active supported bimetallic PdxCu1-x nanocomposites and their application for organic synthesis. Mater Today Chem 48:102944","journal-title":"Mater Today Chem"},{"key":"5620_CR5","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1039\/D5RE00217F","volume":"10","author":"MI Chamanmalik","year":"2025","unstructured":"Chamanmalik MI, Kumbhar PD, Sawant PS, Priyadarshini AN, Kumar A, Sudhanva MS, Rout CS, Yelamaggad CV, Patil SA (2025) Facile access to tetrazoles and 1-substituted benz(imidazoles) using zerovalent copper nanoparticles as an inexpensive and efficient nanocatalyst and its anticancer study. React Chem Eng 10:2721\u20132736","journal-title":"React Chem Eng"},{"key":"5620_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/MCB.22.1.332-342.2002","volume":"22","author":"BD Cook","year":"2002","unstructured":"Cook BD, Dynek JN, Chang W, Shostak G, Smith S (2002) Role for the related poly (ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 22:332\u2013342","journal-title":"Mol Cell Biol"},{"key":"5620_CR7","unstructured":"DeLano WL (2002) The PyMOL molecular graphics system. http:\/\/www.Pymol.Org"},{"key":"5620_CR8","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings. J Chem Inf Model 61:3891\u20133898","journal-title":"J Chem Inf Model"},{"key":"5620_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00018-019-03366-0","volume":"77","author":"T Eisemann","year":"2020","unstructured":"Eisemann T, Pascal JM (2020) Poly (ADP-ribose) polymerase enzymes and the maintenance of genome integrity. Cell Mol Life Sci 77:19\u201333","journal-title":"Cell Mol Life Sci"},{"key":"5620_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/14756366.2017.1344981","volume":"32","author":"AS El-Azab","year":"2017","unstructured":"El-Azab AS, Al-Dhfyan A, Abdel-Aziz AAM, AbouZeid LA, Alkahtani HM, Al-Obaid AM, Al-Gendy MA (2017) Synthesis, anticancer and apoptosis-inducing activities of quinazoline\u2013isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies. J Enzyme Inhib Med Chem 32:935\u2013944","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5620_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","volume":"139","author":"WM Eldehna","year":"2017","unstructured":"Eldehna WM, Abo-Ashour MF, Nocentini A, Gratteri P, Eissa IH, Fares M, Ismael OE, Ghabbour HA, Elaasser MM, Abdel-Aziz HA, Supuran CT (2017) Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eur J Med Chem 139:250\u2013262","journal-title":"Eur J Med Chem"},{"key":"5620_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.141489","volume":"1330","author":"D Gowda","year":"2025","unstructured":"Gowda D, Vinay Kumar DC, Gowda B, Chethan BS, Harsha KB, Shalini V, Sudhanva MS, Shobith R, Rangappa KS (2025) A comprehensive investigation of 4-(4- chlorophenyl)-3-methyl-6,7,8,9-tetrahydroisoxazolo[5, 4-b] quinolin-5(4H)-one as potential anticancer agent: insights from computational and experimental results through crystal structure analysis. J Mol Struct 1330:141489","journal-title":"J Mol Struct"},{"key":"5620_CR13","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1002\/slct.201800053","volume":"3","author":"KB Harsha","year":"2018","unstructured":"Harsha KB, Shobith R, Preetham HD, Swaroop TR, Gilandoust M, Rakesh KS, Rangappa KS (2018) An easy and efficient method for the synthesis of quinoxalines using recyclable and heterogeneous nanomagnetic-supported acid catalyst under solvent-free condition. ChemistrySelect 3:5228\u20135232","journal-title":"ChemistrySelect"},{"key":"5620_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.humpath.2012.04.022","volume":"44","author":"S Hoeller","year":"2013","unstructured":"Hoeller S, Zhou Y, Kanagal-Shamanna R, Xu-Monette ZY, Hoehn D, Bihl M, Young KH (2013) Composite mantle cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a clinicopathologic and molecular study. Hum Pathol 44:110\u2013121","journal-title":"Hum Pathol"},{"key":"5620_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1021\/acs.jmedchem.1c00926","volume":"65","author":"BT Hopkins","year":"2021","unstructured":"Hopkins BT, Bame E, Bajrami B, Black C, Bohnert T, Boiselle C, Lyssikatos J (2021) Discovery and preclinical characterization of BIIB091, a reversible, selective BTK inhibitor for the treatment of multiple sclerosis. J Med Chem 65:1206\u20131224","journal-title":"J Med Chem"},{"key":"5620_CR16","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1002\/jhet.2933","volume":"54","author":"YQ Hu","year":"2017","unstructured":"Hu YQ, Meng LD, Qiang M, Song XF (2017) Design, synthesis, and in vitro anti-mycobacterial evaluation 1H\u20131,2,3-triazole-tethered ciprofloxacin and isatin conjugates. J Heterocyclic Chem 54:3725\u20133729","journal-title":"J Heterocyclic Chem"},{"key":"5620_CR17","first-page":"46955","volume":"6","author":"GS Jagadeesha","year":"2022","unstructured":"Jagadeesha GS, Sudhanva MS, Urarkar A, Anil Kumar BM, Shwetha B, Sridhar BT, Niranjan V, Shobith R, Thimmegowda NR, Rangappa KS (2022) Novel 1,2,5-trisubstuted benzimidazoles potenate apoptosis by mitochondrial dysfunction in panel of cancer cells. ACS Omega 6:46955\u201346971","journal-title":"ACS Omega"},{"key":"5620_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28135041","volume":"28","author":"T Kosmalski","year":"2023","unstructured":"Kosmalski T, Kupczyk D, Baumgart S, Paprocka R, Studzi\u0144ska R (2023) A review of biologically active oxime ethers. Molecules 28:5041","journal-title":"Molecules"},{"key":"5620_CR19","first-page":"318","volume":"6","author":"K Meenakshi","year":"2014","unstructured":"Meenakshi K, Gopal N, Sarangapani M (2014) Synthesis, characterization and antimicrobial activity of some novel schiff and mannich bases of Isatin. Int J Pharm Pharm Sci 6:318\u2013322","journal-title":"Int J Pharm Pharm Sci"},{"key":"5620_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/14756366.2016.1238366","volume":"32","author":"R Meleddu","year":"2017","unstructured":"Meleddu R, Distinto S, Corona A, Tramontano E, Bianco G, Melis C, Cottiglia F, Maccioni E (2017) Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase. J Enzyme Inhib Med Chem 32:130\u2013136","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5620_CR21","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"5620_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12039-018-1540-2","volume":"130","author":"N Rajeev","year":"2018","unstructured":"Rajeev N, Swaroop TR, Anil SM, Kiran KR, Rangappa KS, Sadashiva MP (2018) A sequential one-pot tandem approach for the synthesis of 4-tosyl-5-aryloxazoles from carboxylic acids. J Chem Sci 130:150","journal-title":"J Chem Sci"},{"key":"5620_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102368","volume":"16","author":"SM Rajesh","year":"2025","unstructured":"Rajesh SM, Gowda B, Srinivasa SM, Swaroop TR, Suresh RN, Shalini V, Preetham HD, Shobith R, Rangappa KS (2025) Synthesis of spiro[cyclopropane-isatin] derivatives and their therapeutic potential as anticancer agents against colorectal carcinoma. Results Chem 16:102368","journal-title":"Results Chem"},{"key":"5620_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.70091","volume":"105","author":"SM Rajesh","year":"2025","unstructured":"Rajesh SM, Shivaramu PD, Bhol CS, Swaroop TR, Preetham HD, Suresh RN, Chinnathambi A, Govindasamy C, Alharbi SA, Shalini V, Ahn KS, Rangappa S, Rangappa KS (2025) 1,2,3-Triazole tethered spiro[indoline-oxirane] derivatives induce anticancer effects in human hepatoma cells. Chem Biol Drug des 105:e70091","journal-title":"Chem Biol Drug des"},{"key":"5620_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140265","volume":"1321","author":"D Rekharani","year":"2025","unstructured":"Rekharani D, Vinay Kumar DC, Chethan BS, Deepa Urs MV, Sathisha KR, Lokanath NK, Naveen S (2025) Exploration of crystal structure, supramolecular organization, and computational studies of a novel pyrazole derivative: A structural and theoretical perspectives. J Mol Struct 1321:140265","journal-title":"J Mol Struct"},{"key":"5620_CR26","first-page":"115","volume":"52","author":"G Saravanan","year":"2014","unstructured":"Saravanan G, Alagarsamy V, Dineshkumar P (2014) Anticonvulsant activity of noveln1-(morpholinomethyl)-3-substituted isatin derivatives. Bull Fac Pharm (Cairo Univ) 52:115\u2013124","journal-title":"Bull Fac Pharm (Cairo Univ)"},{"key":"5620_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/smim.1998.0123","volume":"10","author":"AB Satterthwaite","year":"1998","unstructured":"Satterthwaite AB, Li Z, Witte ON (1998) Btk function in B cell development and response. Semin Immunol 10:309\u2013316","journal-title":"Semin Immunol"},{"key":"5620_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.141495","volume":"1330","author":"V Shalini","year":"2025","unstructured":"Shalini V, Kumar DV, Gowda D, Chethan BS, Harsha KB, Rajesh SM, Rangappa KS (2025) Unveiling the structural and theoretical properties of 6-(2-fluoro-3-methylpyridin-4-yl)-2-(4-methoxyphenyl)-N-phenylquinoline-4-carboxamide compound as Sonic Hedgehog protein inhibitor: synthesis, SCXRD, HSA, DFT, Docking and ADMET studies. J Mol Str 1330:141495","journal-title":"J Mol Str"},{"key":"5620_CR29","volume":"19","author":"V Shalini","year":"2024","unstructured":"Shalini V, Priyadarshini AN, Harsha KB, Vinay Kumar DC, Gowda D, Chethan BS, Srinivasa SM, Rangappa S, Rangappa KS (2024) Novel quinoline-4-carboxamide derivatives potentiates apoptosis by targeting PDK1 to overcome chemo-resistance in colorectal cancer: Theoretical and experimental results. Heliyon 19:e38105","journal-title":"Heliyon"},{"key":"5620_CR30","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1016\/j.bmcl.2017.07.069","volume":"27","author":"H Singh","year":"2017","unstructured":"Singh H, Singh JV, Gupta MK, Saxena AK, Sharma S, Nepali K, Bedi PMS (2017) Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: design, synthesis, biological investigation and docking studies. Bioorg Med Chem Lett 27:3974\u20133979","journal-title":"Bioorg Med Chem Lett"},{"key":"5620_CR31","doi-asserted-by":"publisher","DOI":"10.1149\/1945-7111\/ab72ed","volume":"167","author":"TR Swaroop","year":"2020","unstructured":"Swaroop TR, Wang Z-Q, Li QY, Wang H-S (2020) Reductive coupling of aromatic aldehydes and ketones under electrochemical conditions. J Electrochem Soc 167:046504","journal-title":"J Electrochem Soc"},{"key":"5620_CR32","first-page":"2738","volume":"5","author":"C Tejasree","year":"2014","unstructured":"Tejasree C, Kiran G, Rajyalakshmi G, Reddy ARN (2014) Antidiabetic activity of 1-(4-(dimethylamino)benzylidene)-5-(2-oxoindolin-3-ylidene) thiocarbohydrazone in rats. Int J Pharm Sci Res 5:2738\u20132743","journal-title":"Int J Pharm Sci Res"},{"key":"5620_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","volume":"60","author":"AG Thorsell","year":"2017","unstructured":"Thorsell AG, Ekblad T, Karlberg T, Low M, Pinto AF, Tr\u00e9saugues L, Schuler H (2017) Structural basis for potency and promiscuity in poly (ADP-ribose) polymerase (PARP) and tankyrase inhibitors. J Med Chem 60:1262\u20131271","journal-title":"J Med Chem"},{"key":"5620_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.5306\/wjco.v15.i6.755","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang YJ (2024) Tankyrase 2 promotes lung cancer cell malignancy. World J Clin Oncol 15:755","journal-title":"World J Clin Oncol"},{"key":"5620_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124:30\u201339","journal-title":"J Clin Invest"},{"key":"5620_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/cmdc.201402502","volume":"10","author":"MV Westphal","year":"2015","unstructured":"Westphal MV, Wolfst\u00e4dter BT, Plancher J-M, Gatfield J, Carreira EM (2015) Evaluation of tert-butyl isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities. ChemMedChem 10:461\u2013469","journal-title":"ChemMedChem"},{"key":"5620_CR37","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1021\/jacs.6b10234","volume":"139","author":"W Xu","year":"2017","unstructured":"Xu W, Lau YH, Fischer G, Tan YS, Chattopadhyay A, de la Roche M, Itzhaki LS (2017) Macrocyclized extended peptides: inhibiting the substrate-recognition domain of tankyrase. J Am Chem Soc 139:2245\u20132256","journal-title":"J Am Chem Soc"},{"key":"5620_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111700","volume":"183","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhao S-J, Liu Y (2019) 1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships. Eur J Med Chem 183:111700","journal-title":"Eur J Med Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05620-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:03:17Z","timestamp":1791579797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5620"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05620-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}